Agios Pharmaceuticals, Inc.

Q1 2021 13F Holders

Symbol
AGIO
CUSIP
00847X104
Type
Equity
Class
COM
Num filings
191
Total reported value, excl. options
$3.31 B
Manager Report Date Value ($000) Shares Option Type